FROM Josh Sommer
Cancer and the Business of Medicine The annual meeting of the American Society of Clinical Oncology brings together the latest on cancer research and treatment. Patients and their families pray for news of a breakthrough. Businesses look for investments; entrepreneurs look for opportunities. Last week in Chicago, some 4000 studies were presented to 30,000 top experts — but one warned there's "a growing sense that our optimism needs to be tempered a bit." We hear from him and others about how financial conflicts, personal habits and occupational hazards impact inroads against the disease.
Cancer: Big Business and the Painstaking Search for a Cure Five years ago, cancer researchers were predicting "miracle treatments" — even vaccines -- based on the billions being spent on genetics. But the more they know, the more complicated cancer becomes, and even the American Cancer Society has tempered its optimism. Cancer victims, and members of Congress, are increasingly impatient with the slow pace of improvement. Are financial conflicts part of the problem? Given what’s known about personal habits like smoking, about occupational hazards and the environment, should more be spent on prevention?
Terrorism and tweets, hate speech and murder Just days before an election, Britain is coping with a rash of deadly terrorism, and Prime Minister Theresa May is on the defensive. And again today, President Trump has tweeted criticism of the Mayor of London. Later, a double murder in Portland, Oregon has revealed the ugly past of a supposedly “progressive” city. One immediate question: is “hate speech” protected by the First Amendment?
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?